The purpose of this CCP-UK study into the COVID-19 disease to better understand its spread and behaviour by analysing biological samples and data from patients with confirmed cases of the disease across the UK.
Principal Investigator: Dr Huw Masson
A Randomised Evaluation of COVID Therapy trial testing if existing drugs can help patients hospitalised with confirmed COVID-19.
Principal Investigator: Dr Purav Desai
Susceptibility to COVID-19 is almost certainly, in part, genetic. GenOMICC can find the genes that cause susceptibility, which may help us to prioritise treatments to respond to the global crisis.
Principal Investigator: Dr Ross Kitson
HElping Alleviate the Longer-term consequences of COVID-19 (HEAL-COVID): a national platform trial.
Principal Investigator: Dr Anneka Biswas
Vaccines are the most effective way to prevent infectious diseases.
They're designed so they do not give people the infection they're protecting against.
Research into vaccines is the only way to find out which vaccines will work. Researchers need people to take part in their studies so they can find out which possible new vaccine works best.
On this page you can sign up to be contacted about taking part in approved UK coronavirus vaccine studies. This means you'll be joining the COVID-19 vaccine research registry.
If you sign up to be contacted about vaccine studies, only researchers on studies approved by NIHR will be able to contact you.
There are strict rules on safety and confidentiality that all health research, including vaccine studies, must follow.
To sign up to the online NHS Coronavirus Vaccine Registry click here